DUBLIN--(BUSINESS WIRE)--The "Global Infertility Treatment Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023" report has been added to Research and Markets' offering.
The global infertility treatment market is expected to rise at a CAGR of 10.6% during the forecast period 2016-2023. The factors that are driving the market of infertility treatment includes rising infertility cases rising public-private investments/funds, and grants, growing public awareness regarding infertility and the available treatment options and technological upgradation in infertility treatment devices. However the growing concerns related to ART procedures and reduction in efficacy among older women.
Geographically, the infertility treatments market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Globally North America holds the largest share of the infertility treatment market in terms of revenue in 2016, followed by Europe and Asia Pacific region. The factors such as declining fertility rates, high healthcare expenditure, early technological upgradation and adoption, and a rise in the number of same-sex couples are some of the factors that are driving the market in North America region.
The report on global Infertility Treatment market is divided into 4 segments that includes procedure, product type, patient type and end-users. The procedure type segment is further divided into Assisted Reproductive Technology, Artificial Insemination, and Fertility Surgeries. In 2016, the ART is the dominating sub segment in the procedure segment due to rising infertility cases among men & women and high prevalence of lifestyle disorders. The end-user segment of Infertility Treatment includes fertility centers, hospitals & clinics, research institutes, and cryobanks. The fertility centers segment holds the largest share of the infertility treatment market in 2016. On the basis of patient type, the global market for infertility treatment is segmented into male patients and female patients. Report further covers segments of product type which includes instruments, media & consumables, and accessories. Instruments accounted for the largest share of the global infertility treatment market in 2016.
- Cook Group Incorporated (U.S.)
- Esco Micro Pte. Ltd. (Singapore)
- Genea Limited (Australia.)
- Halotech Dna Sl (U.S.)
- Ihmedical A/S (U.S.)
- Irvine Scientific(U.S.)
- Ivftech Aps (Denmark)
- Kitazato (Japan)
- Pantarhei Bioscience B.V. (U.S.)
- Rinovum Women'S Health, Llc. (U.S.)
- Scsa Diagnostics, Inc. (U.K.)
- The Baker Company, Inc.(U.S.)
- The Cooper Companies Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Vitrolife Ab (Sweden)
Key Topics Covered:
2. Market Overview
3. Market Determinants
4. Market Segmentation
5. Competitive Landscape
6. Geographical Analysis
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/hpbznw/global